|
Compilation of Chinese Pharmacopoeia (2010 Edition) gets started
|
|
At the Inaugural Conference of the ninth Chinese Pharmacopoeia Commission and the first General Assembly held on December 8-9, 2007, Chairman of the Commission and Commissioner of SFDA Shao Mingli pointed out that efforts shall be made to conduct research on drug standards, strengthen the management of drug standards, speed up the implementation of National Drug Standards Improving Plan, and improve drug quality control in an all-round manner. The Articles of Chinese Pharmacopoeia Commission and the Outline for Compilation of Chinese Pharmacopoeia(2010 Edition) were passed at the conference.
As the technical organization responsible for organizing the elaboration and revision of National Drug Standards, there are an executive board and 25 subcommittees under the ninth Chinese Pharmacopoeia Commission , consisting of 321 experts and scholars in such fields as clinic, scientific research, teaching, manufacturing, inspection, and management closely related to the work on drug standards, including 24 academicians, with average age of 52.7.
During the speech, Shao Mingli gave a summary of the work achievements of the eighth Chinese Pharmacopoeia Commission , and specified the guidelines, major goals, and the basic principles for the compilation of Chinese Pharmacopoeia (2010 Edition). Besides, he proposed specific requirements for the work on drug standards in the coming stage. The compilation of Chinese Pharmacopoeia (2010 Edition) shall further expand the range of inclusion, cover all the varieties indicated in the National Essential Drugs List, adopt new technologies, improve the standards for high-risk varieties, standardize the styles and contents of the Volumes 1, 2, and 3 of Chinese Pharmacopoeia, and intensify the compilation and publishing of Supplements to the Pharmacopoeia.
| |
|
|
